Background and objective: A variety of different lymph node (LN) staging systems have been developed to describe the lymph node status accurately. We aim to compare the prognostic accuracy of American Joint Committee on Cancer seventh N stage relative to negative number of lymph node (nLN), lymph node ratio (LNR) and log odds of metastatic lymph nodes (LODDS) in rectal adenocarcinoma (RC). Methods: A total of 19 167 Stage II-III rectal cancer patients who underwent surgical resection of rectal adenocarcinoma were identified from Surveillance, Epidemiology and End Results database. Akaike's Information Criterion (AIC) and the Harrell's concordance index (c statistic) were used to evaluate the relative discriminative power of the different LN staging systems. Results: Of the 19 167 patients, 10 958 received preoperative radiotherapy (pre-RT cohort) and 8209 patients were treated with surgical resection directly (SURG cohort). When assessed using categorical cutoff values, LNR has a somewhat better prognostic accuracy both in pre-RT (c-index: 0.62; AIC: 2988.6) and SURG groups (c-index: 0.60; AIC: 3359.8). Further analysis based on different total number of lymph node (TNLN) suggested that when less than 10 lymph nodes were retrieved, LNR exhibited significant superiority (pre-RT: c-index: 0.597, AIC: 1006.8; SURG: c-index: 0.560, AIC: 810.5). When analyzed as a continuous variable, the LODDS system performed the best and was not impacted by TNLN. Conclusion: When assessed as a categorical variable, LNR was the most powerful method to predict survival for Stage II-III RC patients with limited TNLN. Rather, LODDS was the most accurate staging system regardless of the TNLN when LN status was modeled as continuous variable.
Introduction
Rectal cancer (RC) is one of the most common malignant tumors all over the world, with an estimated incidence of 39, 220 new cases in the United States in 2016 (1) . For those cases diagnosed as early stage RC preoperatively, radical resection with or without adjuvant therapy is the recommendation of National Comprehensive Cancer Network (NCCN) Guidelines (2) . While for locally advanced RC (T3-4 and/or node positive), neoadjuvant chemoradiation therapy has been widely accepted as the standard of care.
It is universally perceived that lymph node (LN) metastasis is a strong predictor of poor long-term outcome in RC (3, 4) . Thus, a variety of different LN staging systems have been developed in order to describe the lymph node status accurately (5) . Primarily, the American Joint Committee on Cancer/International Union Against Cancer (AJCC/ UICC) tumor node metastasis (TNM) classification based on the absolute number of positive LN is currently the most widely used staging scheme (5) . Recently, the concept of negative lymph node (nLN) counts has attracted attention as a prognostic indicator and many researchers have confirmed its independent role in RC (6) (7) (8) . However, both the positive number of LNs (pLN) and nLN do not take into account the total number of LNs (TNLN) retrieved at the time of surgery, which has been suggested by many groups to be an independent predictor of survival in rectal cancer regardless of the preoperative chemoradiation therapy (9) (10) (11) . Therefore, lymph node ratio (LNR) system, defined as the ratio of pLNs relative to TNLN, has been proposed and been considered by many investigators to be more accurate than pLN for RC (12) (13) (14) (15) (16) . More recently, several study groups started to question the accuracy of LNR and proposed a novel system, log odds of positive lymph nodes (LODDS), defined as the Natural logarithm of the ratio of the probability of a LN with metastasis versus the probability without metastasis (17) (18) (19) . Lee et al. (18) explored the independent prognostic role of LODDS in RC for the first time but did not compared the discrimination power among different LN staging systems directly.
To date, it is still debatable for the clinical value of different LN staging systems and no previous study has been conducted to compare the prognostic accuracy of these systems in predicting longterm survival in RC with or without neoadjuvant therapy. Therefore, we sought to evaluate the survival predicting performance of different LN staging schemes, including AJCC N stage, nLN, LNR, LODDS and NPR as to identifying the best LN status assessing method in RC adenocarcinoma with or without preoperative radiotherapy by using the Surveillance, Epidemiology and End Results (SEER)-registered database.
Materials and methods

Patient selection in the SEER database
Patient data were obtained from the SEER database (http://seer. cancer.gov/seerstat), which was sponsored by the National Cancer Institute. It currently collects and publishes cancer incidence and survival data covering eighteen population-based cancer registries that represent~28% of the population in the United States. Using the SEER database, we identified 46 074 Stage I-III primary adenocarcinoma of rectum diagnosed and resected between 2004 and 2013. Patients who met the following criteria were included: (a) pathologically diagnosed rectal adenocarcinoma; (b) AJCC Stage II-III; (c) known radiotherapy sequence information; (d) TNLN was at least 1; (e) rectal cancer as the first and only malignant tumor. Patients with unknown information of LN status were excluded. Finally, a total of 19 167 were identified in this study. Patients were categorized into two groups: those treated with preoperative radiotherapy (pre-RT) and those treated with surgery directly (SURG), which includes 10 985 and 8209 patients, respectively.
Statistical analyses
Kaplan-Meier estimator of survival was used to explore differences among the strata stratified by the seventh edition AJCC/UICC N stage, nLN, LNR and LODDS. nLN, LNR and LODDS were evaluated both as a continuous and categorical variable. The LNRs were divided into four groups (LNR1 to LNR5) as follows: LNR = 0, 0 < LNR ≤ 0.25, 0.25 < LNR ≤ 0.50, 0.50 < LNR < 0.75, and 0.75 < LNR ≤ 1.0. LODDS was calculated using an established formula and was separated into five groups (LODDS1 to LODDS5) using the cutoff values advocated by Huang et al. (17, 19) .
The discriminative abilities of the different LN staging systems were evaluated by using the Harrell's concordance index (c statistic) and Akaike's Information Criterion (AIC). Generally, a predictive model with a low AIC indicates a better model fit and a high c statistic represents a better discrimination ability (20) . All statistical analyses were performed using R (version 2.15.0, www.r-project. org).
Results
Patient characteristics
A total of 26 748 rectal cancer patients (12 982 pre-RT and 13 766 SURG) from the SEER database were included in the analysis. There were 3761 (1759 pre-RT and 2002 SURG) rectal cancer-specific deaths in total. The clinical and histopathological characteristics of the patients are shown in Table 1 . The background of the SURG cohort and pre-RT cohort are significantly different based on baseline clinicopathological characteristics. Patients in pre-RT group had a significant higher proportion of young male and higher ratios of T3/4 tumor stage and less Lymph Nodes Yield (P < 0.001).
Impact of LN status on risk of death
ALL cohort
In the whole patients, Kaplan-Meier survival curves based on four LN staging systems are presented in Fig. 1 . Significant survival difference can be detected among the five groups stratified by N stage and nLN staging system ( Fig. 1 , Table 2 ). However, for LNR and LODDS system, no prognostic difference can be found between LNR4 and LNR5 (P = 0.054), LODDS3 and LODDS4 (P = 0.989).
pre-RT cohort
The 5-year CSS of the different N stage categories was: pN0 85.4%, N1a 75.2%, N1b 73.2%, N2a 58.7% and N2b 46.0% ( Table 2) . The N1a and N1b classifications failed to discriminate the prognosis of patients (P = 0.163). The nLN system was able to stratify patients into five distinct prognostic groups: nLN1 46.5%, nLN2 69.3%, nLN3 77.9%, nLN4 81.8% and nLN5 87.5% (P < 0.001, Table 2 ). No significant difference was found between LNR4 and LNR5 (P = 0.496). The 5-year CSS of the different LODDS categories, according to the classification established by Hang et al., was: LODD1 82.8%, LODDS2 64.8%, LODDS3 44.6%, LODDS4 55.4% and LODDS5 24.4%; of note, survival curves of patients in the LODDS3 and LODDS4 categories were overlapped (P = 0.198).
SURG cohort
For the patients received surgical resection directly, both N stage and LNR can stratify patients into five groups with significantly different survival (Fig. 1 , Table 2 ). While for nLN and LODDS system, no prognostic difference can be found between nLN4 and nLN5 (P = 0.253), LODDS3 and LODDS4 (P = 0.268)
Prognostic accuracy of various LN staging systems
ALL cohorts AIC and c-statistic values were used to assess the prognostic discriminatory ability of different LN staging systems (Table 3) . Firstly, we analyzed the prognostic discriminatory ability using the categorical cutoff values of different LN staging systems. In the whole patients, LNR (c-index: 0.618; AIC: 6875.4) showed the best performance than any another staging system. Further analysis based on different TNLN suggested that when limited LNs (TNLN < 10) was examined, LNR(c-index: 0.596; AIC: 1997.6) maintained its best performance. However, when over 15 TNLNs was retrieved, N stage became the best staging system (c-index: 0.646; AIC: 2122.7).
To avoid the impact from different categorical cutoff values, analyses were repeated by using continuous variables in the statistical models. Results showed that the LODDS system significantly outperformed other staging/scoring systems both in pre-RT (c-index: 0.643; AIC: 3382.9) and SURG groups (c-index: 0.659; AIC: 4421.3). Furthermore, the best performance of LODDS was not impacted by the number of TNLN. Of note, nLN was always the worst system in predicting survival.
SURG cohorts & pre-RT cohort
Consistent with the results in the whole cohort, we found that LNR have a somewhat better prognostic accuracy both in pre-RT (c-index: 0.625; AIC: 2988.6) and SURG groups (c-index: 0.600; AIC: 3359.8). When limited LNs (TNLN < 10) was examined, LNR performed best but when over 15 TNLNs was retrieved, N stage became the best staging system both in pre-RT (c-index: 0.653; AIC: 721.2) and SURG cohorts (c-index: 0.624; AIC:1226.1). Similar results can also be found when analyzing different LN staging system as continuous variables. Compared the result from SURG and pre-RT cohort, it showed that the overall performance of LN staging systems in SURG group were better than it in pre-RT cohort.
Scatter plots were plotted to illustrate the relationship among the four classifications. As shown in Fig. 2 , the value of LODDS increased as the positive number of LNs increased and decreased as nLNs increased, reflecting that LODDS was correlated with the number of positive and negative LNs. From Fig. 2A and B, we can see that the distribution of LODDS score was similar to the LNR, and correlation analysis suggested a good agreement between the two staging systems (pre-RT: Pearson correlation: 0.984, P < 0.001; SURG: Pearson correlation: 0.984, P < 0.001). However, when the LNR was 0 or 1, the value of LODDS was heterogeneous, suggesting that the LODDS system may have more discriminatory ability among patients with either very low or high LNR.
Discussion
Lymph node status is a critical prognostic factor for the determination of the postoperative therapeutic scheme and follow-ups in colorectal cancer (21) . Currently, the AJCC seventh edition is still the dominant LN staging system, but the reliability of the number based LN scoring system has recently been questioned (12) (13) (14) (15) (16) . Recently, although the new concept of nLN attracted much attention, it does bear similar innate limitation to pLN: the skills of the surgeon, the actual number of regional lymph nodes or the thoroughness of the pathologist may exert great impact upon the retrieved number of positive or negative LNs (22) . LNR, a ratio based evaluation method for LN status, takes both the number of pLN and TNLN into consideration. It has been shown to be a better independent prognostic parameter than AJCC N staging system in rectal cancer (12) (13) (14) (15) (16) . Nearly all the researchers have confirmed that patients with same N stage can be divided into significantly different prognostic groups by LNR system. LODDS, a novel estimator of the status of LNs, embraces promising possibility to further improve the accuracy of N classification for prognostic assessment. Two recent studies conducted by Hang et al. revealed that LODDS is superior to LNR in RC treated with or without neoadjuvant therapy (17, 19) . In his study, multivariate regression analysis suggested the LNR was no longer associated with CSS after adjusting for LODDS and thus it concluded that LODDS has superior discrimination power over LNR. Nevertheless, this conclusion was not made based on solid evidence and data analysis. What's more, no direct discrimination power analysis was conducted in their study. Unlike previous studies, we cared more about the performance or prognostic accuracy of different LN staging systems in predicting survival for RC. It is proverbial that the accuracy of a staging system to predict long-term survival is pivotal to help guide postoperative treatment decisions and surveillance among cancer patients. Therefore, two notable statistical indicators of AIC and c-index were analyzed to assess the relative discriminative abilities of the four established scoring systems. First of all, we found that nLN was always the worst staging system when analyzed as categorical or continuous variable either in pre-RT or SURG cohort though nLN system can divided patients into several groups with significantly different survival. When LN status was modeled as a continuous variable, the LODDS outperformed other systems both in pre-RT or SURG cohort, whereas when assessed as categorical system, LNR performed best generally. Therefore, it is educible that we decreased the discrimination power of LODDS by applying inadequate cutoff values which was established by Hang et al. (17, 19) .
Actually, it is still controversial about the determination of cutoff values for different LN staging systems. To date, a variety of statistical methods, including the median, ROC statistics (23) (27) . Because of the lack of consensus on cutoff values for different LN systems, we believe that it is better to assess LN status as continuous variable so as to reveal its real performance. Our results support this impression as treating LN system as categorical variable will deteriorate their prognostic power.
Except for LN node status, the TNLN has been confirmed to have great impact on the prognosis of patients (28, 29) . Recommendations for the minimum number of nodes examined range from 10 to 23 (29) (30) (31) , but no standard has been reached. Therefore, further subgroup analysis based on different TNLN was conducted to study the prognostic accuracy of different LN staging systems. In our study, we separated patients into three groups according to TNLN: TNLN < 10, TNLN < 15 and TNLN > 15. When examined as categorical variables, LNR was the best predicting model among patients with less than 10 TNLN. However, among patients with over 15 TNLN, the AJCC N stage performed best both in pre-RT and SURG cohorts. When analyzed as continuous variables, LODDS performed always the most accurately regardless of the TNLN and implement of preoperative radiotherapy. Collectively, LODDS seems to be the most reliable system in predicting survival of RC.
Considering the neoadjuvant therapy can reduces the number of evaluable nodes, thus influencing the information revealed by LN staging system (32,33), we separated our patients into two cohorts according to the implementation of preoperative radiotherapy. Basic clinicopathologic feature of the groups were significantly different from each other and over 30% of patients in pre-RT group had less than 10 lymph node examined, which increased the necessity of analyzing the two cohorts separately. Immune response, fibrosis (34) and size induction (1-2 mm) of non-metastatic nodes (35) caused by preoperative radiation may all contribute to the decreased number of lymph node yield. Though the different background and evaluable nodes between the SURG and pre-RT cohort, we found that the performance of different LN staging systems maintained uniform tendency. However, the overall prognostic accuracy of the four staging systems for pre-RT cohort was relatively worse than that for SURG cohort. Therefore, it is assumable that preoperative radiotherapy may devalue the LN staging system. Hence, how to identify and quantify the influence of preoperative therapy on the performance of LN staging systems in rectal cancer would be a good research point.
To our knowledge, this is the first study designed to compare the discrimination power of AJCC N stage, nLN, LNR and LODDS directly in RC treated with or without pre-RT. Inevitably, several limitations do exist in our study. First of all, our study is a retrospective study based on SEER database, so selection bias cannot be totally avoided. Secondly, as the definition of tumor deposit keeps changing for decades, the data of N1c stage was not included in this study. Thirdly, patients with mucinous or signet ring cell carcinoma were not identified in this study, for the biological behavior and metastasis regulations of LNs of mucinous and signet ring cell carcinoma are quite different from adenocarcinoma. Finally, the SEER database lacked some clinical information including the complete information of neoadjuvant therapy, quality of surgery and location of metastatic LNs. Such drawbacks are inherent to any retrospective, population-based study. However, the sample size of this present study, which we believe to be the largest to date, and the long duration of follow up can compensate to a great extent and provide a comprehensive review of the current LN staging system in rectal cancer.
In conclusion, LNR was, when assessed as a categorical variable, the most powerful method to predict survival for RC patients with limited TNLN. Rather, LODDS was the most accurate staging system regardless of the TNLN when LN status was modeled as continuous variable.
